ImCheck Therapeutics Competitors and Similar CompaniesClear all
ImCheck Therapeutics's competitors and similar companies include MedDay, Carmot Therapeutics, Rubius Therapeutics and Adicet Bio.
 ImCheck Therapeutics ImCheck Therapeutics is a biotech company developing the next generation of immune checkpoint modulators . |  MedDay MedDay is a biotechnology company specializing in therapeutics for the treatment of neuro-metabolic diseases. |  Carmot Therapeutics Carmot Therapeutics is a clinical-stage biotechnology company focused on the discovery of disease-modifying therapies in metabolic disease and cancer. | |||
Founding Date | Founding Date 2015 | Founding Date 2011 | Founding Date 2008 | Founding Date 2013 | Founding Date 2016 |
Type | Type Private | Type Private | Type Subsidiary | Type Public | Type Public |
Tags | |||||
Locations | Locations Marseille, FR HQ | Locations Clichy, FR HQ Paris, FR Boston, US | Locations Berkeley, US HQ | Locations Cambridge, US HQ Smithfield, US | Locations Redwood City, US HQ Boston, US |
Employees | Employees 57 | Employees 3710% decrease | Employees 109% decrease | Employees 17423% increase | Employees 1438% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 7.5 m | Valuation ($) 116.2 m |
Financial | |||||
Net income | Net income N/A | Net income N/A | Net income ($38.8m) (FY, 2022) | Net income ($179.7m) (FY, 2022) | Net income ($116.8m) (FY, 2025) |
Funding | |||||
Latest funding round | Latest funding round $ 53.2m (over 6 years ago) | Latest funding round $ 38.5m (about 10 years ago) | Latest funding round N/A | Latest funding round N/A | Latest funding round N/A |
Total funding raised | Total funding raised $ 76.1m | Total funding raised $ 48.9m | Total funding raised $ 74.8m | Total funding raised $ 245m | Total funding raised $ 145.6m |
For sources of this data, please see the company profile
View Company Profiles
MedDay
HQ
Clichy, FR
Employees
37↓ 10% decrease
MedDay is a biotechnology company specializing in therapeutics for the treatment of neuro-metabolic diseases.
View companyCarmot Therapeutics
HQ
Berkeley, US
Carmot Therapeutics is a clinical-stage biotechnology company focused on the discovery of disease-modifying therapies in metabolic disease and cancer.
View company
Rubius Therapeutics
HQ
Cambridge, US
Employees
174↑ 23% increase
Rubius is developing a new class of drugs, Red-Cell Therapeutics™.
View company
Adicet Bio
HQ
Redwood City, US
Employees
143↑ 8% increase
Adicet Bio is a biotechnology company that develops therapies for cancer diseases.
View company